4
Changes in Ownership
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-21-020542
Options or other derivatives
- CFO acquired 0 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Raines Heather · CFO
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-16 | Grant or award : show line 1 in the form 8% Unsecured Convertible Promissory Note due 2022 | +0 | $200,000.00 | $0 | D |
Loading xslF345X03/ownership.xml…